Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Flanigan

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
The Lancet. Neurology|June 16, 2016
Duchenne muscular dystrophy: meeting the therapeutic challengeKevin M Flanigan
Human Mutation|May 30, 2009
Mutation-specific database and bioinformatics resource for DMDKevin M Flanigan
Seminars in Neurology|November 3, 2012
The muscular dystrophiesKevin M Flanigan
Neurologic Clinics|July 20, 2014
Duchenne and Becker muscular dystrophiesKevin M Flanigan
Seminars in Pediatric Neurology|April 24, 2021
Update in the MucopolysaccharidosesKim L McBride, Kevin M Flanigan
Current Opinion in Neurology|July 26, 2019
Update in Duchenne and Becker muscular dystrophyMegan A Waldrop, Kevin M Flanigan
Neurology. Genetics|October 21, 2016
Reassessing carrier status for dystrophinopathiesTara M Newcomb, Kevin M Flanigan
Progress in Molecular Biology and Translational Science|June 27, 2021
Gene editing and modulation for Duchenne muscular dystrophyAnthony A Stephenson, Kevin M Flanigan
Physical Medicine and Rehabilitation Clinics of North America|September 4, 2012
A practical approach to molecular diagnostic testing in neuromuscular diseasesW David Arnold, Kevin M Flanigan
Pediatric Clinics of North America|May 30, 2015
Genetics and emerging treatments for Duchenne and Becker muscular dystrophyNicolas Wein, Lindsay Alfano, Kevin M Flanigan
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
The Lancet. Neurology|June 16, 2016
Duchenne muscular dystrophy: meeting the therapeutic challengeKevin M Flanigan
Human Mutation|May 30, 2009
Mutation-specific database and bioinformatics resource for DMDKevin M Flanigan
Seminars in Neurology|November 3, 2012
The muscular dystrophiesKevin M Flanigan
Neurologic Clinics|July 20, 2014
Duchenne and Becker muscular dystrophiesKevin M Flanigan
Seminars in Pediatric Neurology|April 24, 2021
Update in the MucopolysaccharidosesKim L McBride, Kevin M Flanigan
Current Opinion in Neurology|July 26, 2019
Update in Duchenne and Becker muscular dystrophyMegan A Waldrop, Kevin M Flanigan
Neurology. Genetics|October 21, 2016
Reassessing carrier status for dystrophinopathiesTara M Newcomb, Kevin M Flanigan
Progress in Molecular Biology and Translational Science|June 27, 2021
Gene editing and modulation for Duchenne muscular dystrophyAnthony A Stephenson, Kevin M Flanigan
Physical Medicine and Rehabilitation Clinics of North America|September 4, 2012
A practical approach to molecular diagnostic testing in neuromuscular diseasesW David Arnold, Kevin M Flanigan
Pediatric Clinics of North America|May 30, 2015
Genetics and emerging treatments for Duchenne and Becker muscular dystrophyNicolas Wein, Lindsay Alfano, Kevin M Flanigan
Pageof 17